HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetic Ingredient Review Report Status – March 2018

This article was originally published in The Rose Sheet

Executive Summary

Chart: Data compiled by Rose Sheet from information in CIR reports and the Expert Panel’s March 5-6 meeting.

You may also be interested in...



CIR’s Ginkgo Biloba Review Illustrates Growing Botanical Challenges

The Cosmetic Ingredient Review Expert Panel issued a tentative insufficient data report for Ginkgo biloba-derived ingredients at its March 5-6 meeting. The panel’s struggle to map available ingredient information and toxicity data to specific uses in the cosmetics sector signals botanical review challenges that are likely to become only more frequent.

CIR Panel's Parabens Review Leaning Toward Safe, But 'Insufficient Data' For Now

Cosmetic Ingredient Review’s independent experts will continue to mull new safety information for parabens, as well as input from a P&G expert, but the panel is inclined to determine the preservatives safe as used in an assessment that could differ “significantly” from European conclusions. 

AAOS 2021: A Closer Look At Think Surgical’s Active, Open-Implant Orthopedic Robot And What’s Ahead

Medtech Insight sat down with Think Surgical’s CFO Paul Weiner at the recent AAOS conference to discuss the roll-out of the next-generation TSolution One TKA robot and company plans.

Topics

UsernamePublicRestriction

Register

RS121512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel